Clinical Trial

The Effects of Neoadjuvant Tislelizumab Combined With Chemotherapy in Locally Advanced MSS Rectal Cancer

Name: The Effects of Neoadjuvant Tislelizumab Combined With Chemotherapy in Locally Advanced MSS Rectal Cancer — clinical trial record (NCT06254521)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Record status

This record was last updated February 12, 2024 (before its estimated December 30, 2024 completion). Its status may not reflect the trial's current state.

Summary

This study aims to elucidate the effects of neoadjuvant Tislelizumab combined with chemotherapy in locally advanced MSS rectal cancer.

Trial Details

NCT Number	NCT06254521
Lead Sponsor	First Affiliated Hospital of Guangxi Medical University
Conditions	Rectal Cancer, Rectal Cancer Stage II, Rectal Cancer Stage III
Enrollment	60 participants
Start Date	2024-02-22
Primary Completion	2024-12-30 (estimated)
Study Completion	2027-12-30 (estimated)
Updated on ClinicalTrials.gov	2024-02-12